Iranian Journal of Radiology

Published by: Shiraz University of Medical Sciences

Diffusion-Weighted Imaging and Proton Magnetic Resonance Spectroscopy Findings in Osteosarcoma Versus Normal Muscle

Mahrooz Malek 1 , Mohamad Ali Kazemi 1 , * , Sadegh Saberi 2 , Hassan Hashemi 1 and Behnaz Moradi 1
Authors Information
1 Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Medical Imaging Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Orthopedic Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Journal of Radiology: October 2017, 14 (4); e13937
  • Published Online: June 11, 2017
  • Article Type: Research Article
  • Received: April 19, 2016
  • Revised: February 10, 2017
  • Accepted: March 11, 2017
  • DOI: 10.5812/iranjradiol.13937

To Cite: Malek M, Kazemi M A, Saberi S, Hashemi H, Moradi B. et al. Diffusion-Weighted Imaging and Proton Magnetic Resonance Spectroscopy Findings in Osteosarcoma Versus Normal Muscle, Iran J Radiol. 2017 ;14(4):e13937. doi: 10.5812/iranjradiol.13937.

Copyright: Copyright © 2017, Iranian Journal of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Xing D, Qasem SA, Owusu K, Zhang K, Siegal GP, Wei S. Changing prognostic factors in osteosarcoma: analysis of 381 cases from two institutions. Hum Pathol. 2014;45(8):1688-96. doi: 10.1016/j.humpath.2014.04.010. [PubMed: 24931466].
  • 2. Savage SA, Mirabello L. Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma. 2011;2011.
  • 3. Wittig JC, Bickels J, Priebat D, Jelinek J, Kellar-Graney K, Shmookler B, et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician. 2002;65(6):1123-32. [PubMed: 11925089].
  • 4. Chung WJ, Chung HW, Shin MJ, Lee SH, Lee MH, Lee JS, et al. MRI to differentiate benign from malignant soft-tissue tumours of the extremities: a simplified systematic imaging approach using depth, size and heterogeneity of signal intensity. Br J Radiol. 2014.
  • 5. Fayad LM, Wang X, Salibi N, Barker PB, Jacobs MA, Machado AJ, et al. A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T. AJR Am J Roentgenol. 2010;195(1):W69-75. doi: 10.2214/AJR.09.3718. [PubMed: 20566784].
  • 6. Costa FM, Canella C, Gasparetto E. Advanced magnetic resonance imaging techniques in the evaluation of musculoskeletal tumors. Radiol Clin North Am. 2011;49(6):1325-58. vii-viii. doi: 10.1016/j.rcl.2011.07.014. [PubMed: 22024301].
  • 7. Deshmukh S, Subhawong T, Carrino JA, Fayad L. Role of MR spectroscopy in musculoskeletal imaging. Indian J Radiol Imaging. 2014;24(3):210-6. doi: 10.4103/0971-3026.137024. [PubMed: 25114383].
  • 8. Wang CK, Li CW, Hsieh TJ, Chien SH, Liu GC, Tsai KB. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Radiology. 2004;232(2):599-605. doi: 10.1148/radiol.2322031441. [PubMed: 15286325].
  • 9. Abrantes AM, Rio J, Tavares LC, Carvalho RA, Botelho MF. Magnetic resonance spectroscopy in cancer diagnostics. Oncol Rev. 2011;4(3):177. doi: 10.4081/oncol.2010.177.
  • 10. Maheshwari SR, Mukherji SK, Neelon B, Schiro S, Fatterpekar GM, Stone JA, et al. The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy. AJNR Am J Neuroradiol. 2000;21(10):1930-5. [PubMed: 11110549].
  • 11. Fayad LM, Barker PB, Bluemke DA. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy. Semin Musculoskelet Radiol. 2007;11(3):240-5. doi: 10.1055/s-2008-1038313. [PubMed: 18260034].
  • 12. Lee CW, Lee JH, Kim DH, Min HS, Park BK, Cho HS, et al. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification. Clin Imaging. 2010;34(1):47-52. doi: 10.1016/j.clinimag.2009.03.013. [PubMed: 20122519].
  • 13. Fayad LM, Jacobs MA, Wang X, Carrino JA, Bluemke DA. Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology. 2012;265(2):340-56. doi: 10.1148/radiol.12111740. [PubMed: 23093707].
  • 14. Malek M, Pourashraf M, Mousavi AS, Rahmani M, Ahmadinejad N, Alipour A, et al. Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI. Asian Pac J Cancer Prev. 2015;16(8):3407-12. [PubMed: 25921153].
  • 15. Khoo MM, Tyler PA, Saifuddin A, Padhani AR. Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review. Skeletal Radiol. 2011;40(6):665-81. doi: 10.1007/s00256-011-1106-6. [PubMed: 21311884].
  • 16. Oka K, Yakushiji T, Sato H, Hirai T, Yamashita Y, Mizuta H. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol. 2010;39(2):141-6. doi: 10.1007/s00256-009-0830-7. [PubMed: 19924412].
  • 17. Dudeck O, Zeile M, Pink D, Pech M, Tunn PU, Reichardt P, et al. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas. J Magn Reson Imaging. 2008;27(5):1109-13. doi: 10.1002/jmri.21358. [PubMed: 18425832].
  • 18. Schieda N, Al-Dandan O, El-Khodary M, Shabana W. Low b-value (black blood) respiratory-triggered fat-suppressed single-shot spin-echo echo-planar imaging (EPI) of the liver: comparison of image quality at 1.5 and 3 T. Clin Radiol. 2014;69(11):1136-41. doi: 10.1016/j.crad.2014.06.017. [PubMed: 25060933].
  • 19. Doganay S, Altinok T, Alkan A, Kahraman B, Karakas HM. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors. Eur J Radiol. 2011;79(2):e33-7. doi: 10.1016/j.ejrad.2010.12.089. [PubMed: 21376496].
  • 20. Hayashida Y, Yakushiji T, Awai K, Katahira K, Nakayama Y, Shimomura O, et al. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results. Eur Radiol. 2006;16(12):2637-43. doi: 10.1007/s00330-006-0342-y. [PubMed: 16909220].
  • 21. Yakushiji T, Oka K, Sato H, Yorimitsu S, Fujimoto T, Yamashita Y, et al. Characterization of chondroblastic osteosarcoma: gadolinium-enhanced versus diffusion-weighted MR imaging. J Magn Reson Imaging. 2009;29(4):895-900. doi: 10.1002/jmri.21703. [PubMed: 19306430].
  • 22. Oya N, Aoki J, Shinozaki T, Watanabe H, Takagishi K, Endo K. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor. Radiat Med. 2000;18(3):193-8. [PubMed: 10972550].
  • 23. Fayad LM, Bluemke DA, McCarthy EF, Weber KL, Barker PB, Jacobs MA. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging. 2006;23(1):23-8. doi: 10.1002/jmri.20448. [PubMed: 16315208].
  • 24. Fayad LM, Barker PB, Jacobs MA, Eng J, Weber KL, Kulesza P, et al. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. AJR Am J Roentgenol. 2007;188(6):1513-20. doi: 10.2214/AJR.06.0935. [PubMed: 17515370].
  • 25. Nelson SJ. Multivoxel magnetic resonance spectroscopy of brain tumors. Mol Cancer Ther. 2003;2(5):497-507. [PubMed: 12748312].
  • 26. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology. 1993;187(1):219-27. doi: 10.1148/radiology.187.1.8451417. [PubMed: 8451417].
  • 27. Qi ZH, Li CF, Li ZF, Zhang K, Wang Q, Yu DX. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Chin Med J (Engl). 2009;122(1):39-43. [PubMed: 19187615].
  • 28. Fayad LM, Salibi N, Wang X, Machado AJ, Jacobs MA, Bluemke DA, et al. Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. AJR Am J Roentgenol. 2010;194(1):W73-9. doi: 10.2214/AJR.09.3125. [PubMed: 20028894].
  • 29. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Pediatric and adolescent osteosarcoma. Springer; 2009.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader